For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Read Today's Digital Edition
Place Your Legal Notices
Menu
You have to be a subscriber to view this page.

John E. Wehrli

See more on John E. Wehrli

Shareholder
Greenberg Traurig, LLP



John E. Wehrli is also an AI & Neuroscience Advisor to Lionheart Ventures, a San Francisco-based venture capital firm focused on AI, neurotechnology and frontier mental health, and a computational and behavioral neuroscientist and life sciences attorney. He served as an invited delegate and participated in two working groups at Asilomar for the Brain and Mind 2026, where he is helping draft the governance documents emerging from the summit. He can be reached via LinkedIn.



Columns
Title Category Published
The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit Space Law/Aviation/Aerospace, Health Care, Pharmaceuticals, Biotech Feb. 25, 2026
Title Category Published
The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit Space Law/Aviation/Aerospace, Health Care, Pharmaceuticals, Biotech Feb. 25, 2026